Early detection improves cancer survival rates. Autoantibodies can appear very early in disease, often long before onset of symptoms.

Read the white paper to learn:

  • Mechanisms that induce autoantibodies in cancer
  • Discovering autoantibody panels predictive of patient outcomes and responses to therapy
  • Key approaches to screening for autoantibodies with high specificity and sensitivity